{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:57:45Z","timestamp":1791183465750,"version":"4.1.0"},"reference-count":33,"publisher":"American Association for Cancer Research (AACR)","issue":"6","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Galectin-7 is found mainly in stratified squamous epithelia as well as in various other types of cancer cells. As with other members of the galectin family, the expression of galectin-7 has been shown to negatively regulate the development of some tumors while correlating with the progression of other tumor types. For example, up-regulation of galectin-7 is associated with rat mammary carcinomas and with progression to T-cell malignancy. Here, we provide evidence indicating that galectin-7 functions as an important molecule in the dissemination of lymphoma cells in vivo. We found that stable transfection of lymphoma cells with a plasmid encoding antisense galectin-7 cDNA significantly inhibited the dissemination and invasion of lymphoma cells to peripheral organs, thereby increasing the survival of mice. We also found that inhibition of galectin-7 in aggressive lymphoma cells correlated with a decreased invasion of tumor cells in target organs and a reduced expression of matrix metalloproteinase-9, a gene associated with a poor prognosis in non\u2013Hodgkin's lymphoma. We finally examined the expression of galectin-7 in 50 specimens of different mature B-cell neoplasms and found high galectin-7 expression levels in a significant proportion of mature B-cell neoplasms but not in normal B cells. Taken together, these findings suggest that galectin-7 is a potential therapeutic target in the treatment of lymphoid malignancies. [Cancer Res 2007;67(6):2824\u20139]<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-3891","type":"journal-article","created":{"date-parts":[[2007,3,15]],"date-time":"2007-03-15T17:49:30Z","timestamp":1173980970000},"page":"2824-2829","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Galectin-7 in Lymphoma: Elevated Expression in Human Lymphoid Malignancies and Decreased Lymphoma Dissemination by Antisense Strategies in Experimental Model"],"prefix":"10.1158","volume":"67","author":[{"given":"Me\u0301lanie","family":"Demers","sequence":"first","affiliation":[{"name":"1INRS-Institut Armand-Frappier, University of Que\u0301bec, Laval, Que\u0301bec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Biron-Pain","sequence":"additional","affiliation":[{"name":"1INRS-Institut Armand-Frappier, University of Que\u0301bec, Laval, Que\u0301bec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose\u0301e","family":"He\u0301bert","sequence":"additional","affiliation":[{"name":"2Banque de Cellules Leuce\u0301miques du Que\u0301bec, Centre de Recherche Guy-Bernier, Maisonneuve-Rosemont Hospital, Montre\u0301al, Que\u0301bec, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Lamarre","sequence":"additional","affiliation":[{"name":"1INRS-Institut Armand-Frappier, University of Que\u0301bec, Laval, Que\u0301bec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Magnaldo","sequence":"additional","affiliation":[{"name":"3Centre National de la Recherche Scientifique, UPR 2169, \u201cInstabilite\u0301 Ge\u0301ne\u0301tique et Cancer,\u201d Institut Gustave-Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"St-Pierre","sequence":"additional","affiliation":[{"name":"1INRS-Institut Armand-Frappier, University of Que\u0301bec, Laval, Que\u0301bec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,3,15]]},"reference":[{"key":"2022061623230754200_B1","doi-asserted-by":"crossref","unstructured":"Barondes SH, Cooper DN, Gitt MA, Leffler H. Galectins. Structure and function of a large family of animal lectins. J Biol Chem\u20081994; 269: 20807\u201310.","DOI":"10.1016\/S0021-9258(17)31891-4"},{"key":"2022061623230754200_B2","doi-asserted-by":"crossref","unstructured":"Henrick K, Bawumia S, Barboni EA, Mehul B, Hughes RC. Evidence for subsites in the galectins involved in sugar binding at the nonreducing end of the central galactose of oligosaccharide ligands: sequence analysis, homology modeling, and mutagenesis studies of hamster galectin-3. Glycobiology\u20081998; 8: 45\u201357.","DOI":"10.1093\/glycob\/8.1.45"},{"key":"2022061623230754200_B3","doi-asserted-by":"crossref","unstructured":"Barboni EA, Bawumia S, Henrick K, Hughes RC. Molecular modeling and mutagenesis studies of the N-terminal domains of galectin-3: evidence for participation with the C-terminal carbohydrate recognition domain in oligosaccharide binding. Glycobiology\u20082000; 10: 1201\u20138.","DOI":"10.1093\/glycob\/10.11.1201"},{"key":"2022061623230754200_B4","doi-asserted-by":"crossref","unstructured":"Ochieng J, Furtak V, Lukyanov P. Extracellular functions of galectin-3. Glycoconj J\u20082004; 19: 527\u201335.","DOI":"10.1023\/B:GLYC.0000014082.99675.2f"},{"key":"2022061623230754200_B5","doi-asserted-by":"crossref","unstructured":"Perillo NL, Pace KE, Seilhamer JJ, Baum LG. Apoptosis of T cells mediated by galectin-1. Nature\u20081995; 378: 736\u20139.","DOI":"10.1038\/378736a0"},{"key":"2022061623230754200_B6","doi-asserted-by":"crossref","unstructured":"Chung CD, Patel VP, Moran M, Lewis LA, Miceli MC. Galectin-1 induces partial TCR \u03b6-chain phosphorylation and antagonizes processive TCR signal transduction. J Immunol\u20082000; 165: 3722\u20139.","DOI":"10.4049\/jimmunol.165.7.3722"},{"key":"2022061623230754200_B7","doi-asserted-by":"crossref","unstructured":"Walzel H, Blach M, Hirabayashi J, Kasai KI, Brock J. Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells. Glycobiology\u20082000; 10: 131\u201340.","DOI":"10.1093\/glycob\/10.2.131"},{"key":"2022061623230754200_B8","doi-asserted-by":"crossref","unstructured":"Demetriou M, Granovsky M, Quaggin S, Dennis JW. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature\u20082001; 409: 733\u20139.","DOI":"10.1038\/35055582"},{"key":"2022061623230754200_B9","doi-asserted-by":"crossref","unstructured":"Kasai K, Hirabayashi J. Galectins: a family of animal lectins that decipher glycocodes. J Biochem (Tokyo)\u20081996; 119: 1\u20138.","DOI":"10.1093\/oxfordjournals.jbchem.a021192"},{"key":"2022061623230754200_B10","doi-asserted-by":"crossref","unstructured":"Liu FT, Rabinovich GA. Galectins as modulators of tumour progression. Nat Rev Cancer\u20082005; 5: 29\u201341.","DOI":"10.1038\/nrc1527"},{"key":"2022061623230754200_B11","doi-asserted-by":"crossref","unstructured":"Madsen P, Rasmussen HH, Flint T, et al. Cloning, expression, and chromosome mapping of human galectin-7. J Biol Chem\u20081995; 270: 5823\u20139.","DOI":"10.1074\/jbc.270.11.5823"},{"key":"2022061623230754200_B12","doi-asserted-by":"crossref","unstructured":"Lu J, Pei H, Kaeck M, Thompson, HJ. Gene expression changes associated with chemically induced rat mammary carcinogenesis. Mol Carcinog\u20081997; 20: 204\u201315.","DOI":"10.1002\/(SICI)1098-2744(199710)20:2<204::AID-MC7>3.0.CO;2-M"},{"key":"2022061623230754200_B13","doi-asserted-by":"crossref","unstructured":"Rorive S, Eddafali B, Fernandez S, et al. Changes in galectin-7 and cytokeratin-19 expression during the progression of malignancy in thyroid tumors: diagnostic and biological implications. Mod Pathol\u20082002; 15: 1294\u2013301.","DOI":"10.1097\/01.MP.0000037306.19083.28"},{"key":"2022061623230754200_B14","doi-asserted-by":"crossref","unstructured":"Moisan S, Demers M, Mercier J, Magnaldo T, Potworowski EF, St-Pierre Y. Upregulation of galectin-7 in murine lymphoma cells is associated with progression toward an aggressive phenotype. Leukemia\u20082003; 17: 751\u20139.","DOI":"10.1038\/sj.leu.2402870"},{"key":"2022061623230754200_B15","doi-asserted-by":"crossref","unstructured":"Lalancette M, Aoudjit F, Potworowski EF, St-Pierre Y. Resistance of ICAM-1-deficient mice to metastasis overcome by increased aggressiveness of lymphoma cells. Blood\u20082000; 95: 314\u20139.","DOI":"10.1182\/blood.V95.1.314.001k32_314_319"},{"key":"2022061623230754200_B16","doi-asserted-by":"crossref","unstructured":"Bernerd F, Sarasin A, Magnaldo T. Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc Natl Acad Sci U S A\u20081999; 96: 11329\u201334.","DOI":"10.1073\/pnas.96.20.11329"},{"key":"2022061623230754200_B17","doi-asserted-by":"crossref","unstructured":"St John JA, Key B. Expression of galectin-1 in the olfactory nerve pathway of rat. Brain Res Dev Brain Res\u20081999; 117: 171\u20138.","DOI":"10.1016\/S0165-3806(99)00118-2"},{"key":"2022061623230754200_B18","unstructured":"Tenne-Brown J, Puche AC, Key B. Expression of galectin-1 in the mouse olfactory system. Int J Dev Biol\u20081998; 42: 791\u20139."},{"key":"2022061623230754200_B19","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization classification of tumors. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001."},{"key":"2022061623230754200_B20","doi-asserted-by":"crossref","unstructured":"Demers M, Magnaldo T, St-Pierre Y. A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression. Cancer Res\u20082005; 65: 5205\u201310.","DOI":"10.1158\/0008-5472.CAN-05-0134"},{"key":"2022061623230754200_B21","doi-asserted-by":"crossref","unstructured":"Daniels MA, Hogquist KA, Jameson SC. Sweet \u2018n\u2019 sour: the impact of differential glycosylation on T cell responses. Nat Immunol\u20082002; 3: 903\u201310.","DOI":"10.1038\/ni1002-903"},{"key":"2022061623230754200_B22","doi-asserted-by":"crossref","unstructured":"Allione A, Wells V, Forni G, Mallucci L, Novelli F. \u03b2-Galactoside-binding protein (\u03b2GBP) alters the cell cycle, up-regulates expression of the \u03b1- and \u03b2-chains of the IFN-\u03b3 receptor, and triggers IFN-\u03b3-mediated apoptosis of activated human T lymphocytes. J Immunol\u20081998; 161: 2114\u20139.","DOI":"10.4049\/jimmunol.161.5.2114"},{"key":"2022061623230754200_B23","doi-asserted-by":"crossref","unstructured":"Sturm A, Lensch M, Andre S, et al. Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J Immunol\u20082004; 173: 3825\u201337.","DOI":"10.4049\/jimmunol.173.6.3825"},{"key":"2022061623230754200_B24","unstructured":"Hua J, Muschel RJ. Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system. Cancer Res\u20081996; 56: 5279\u201384."},{"key":"2022061623230754200_B25","doi-asserted-by":"crossref","unstructured":"Saussez S, Cucu DR, Decaestecker C, et al. Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer. Ann Surg Oncol\u20082006; 13: 999\u20131009.","DOI":"10.1245\/ASO.2006.08.033"},{"key":"2022061623230754200_B26","unstructured":"Kossakowska AE, Urbanski SJ, Huchcroft SA, Edwards DR. Relationship between the clinical aggressiveness of large cell immunoblastic lymphomas and expression of 92 kDa gelatinase (type IV collagenase) and tissue inhibitor of metalloproteinases-1 (TIMP-1) RNAs. Oncol Res\u20081992; 4: 233\u201340."},{"key":"2022061623230754200_B27","doi-asserted-by":"crossref","unstructured":"Kossakowska AE, Huchcroft SA, Urbanski SJ, Edwards DR. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas, and malignant non-Hodgkin's lymphomas in humans. Br J Cancer\u20081996; 73: 1401\u20138.","DOI":"10.1038\/bjc.1996.266"},{"key":"2022061623230754200_B28","unstructured":"Ostergaard M, Rasmussen HH, Nielsen H, et al. Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res\u20081997; 57: 4111\u20137."},{"key":"2022061623230754200_B29","doi-asserted-by":"crossref","unstructured":"Kuwabara I, Kuwabara Y, Yang, RY et al. Galectin-7 (PIG1) exhibits pro-apoptotic function through JNK activation and mitochondrial cytochrome c release. J Biol Chem\u20082002; 277: 3487\u201397.","DOI":"10.1074\/jbc.M109360200"},{"key":"2022061623230754200_B30","doi-asserted-by":"crossref","unstructured":"Kopitz J, Andre S, von Reitzenstein C, et al. Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells. Oncogene\u20082003; 22: 6277\u201388.","DOI":"10.1038\/sj.onc.1206631"},{"key":"2022061623230754200_B31","doi-asserted-by":"crossref","unstructured":"Mueller MM, Fusenig NE. Friends or foes\u2014bipolar effects of the tumour stroma in cancer. Nat Rev Cancer\u20082004; 4: 839\u201349.","DOI":"10.1038\/nrc1477"},{"key":"2022061623230754200_B32","doi-asserted-by":"crossref","unstructured":"Dumic J, Dabelic S, Flogel M. Galectin-3: an open-ended story. Biochim Biophys Acta\u20082006; 1760: 616\u201335.","DOI":"10.1016\/j.bbagen.2005.12.020"},{"key":"2022061623230754200_B33","doi-asserted-by":"crossref","unstructured":"Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature\u20081997; 389: 300\u20135.","DOI":"10.1038\/38525"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/6\/2824\/2578466\/2824.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/6\/2824\/2578466\/2824.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:46:54Z","timestamp":1683766014000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/6\/2824\/534019\/Galectin-7-in-Lymphoma-Elevated-Expression-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,15]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2007,3,15]]},"published-print":{"date-parts":[[2007,3,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-3891","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,15]]}}}